Literature DB >> 34392925

Novel Tracers and Radionuclides in PET Imaging.

Christian Mason1, Grayson R Gimblet2, Suzanne E Lapi3, Jason S Lewis4.   

Abstract

The use of PET imaging agents in oncology, cardiovascular disease, and neurodegenerative disease shows the power of this technique in evaluating the molecular and biological characteristics of numerous diseases. These agents provide crucial information for designing therapeutic strategies for individual patients. Novel PET tracers are in continual development and many have potential use in clinical and research settings. This article discusses the potential applications of tracers in diagnostics, the biological characteristics of diseases, the ability to provide prognostic indicators, and using this information to guide treatment strategies including monitoring treatment efficacy in real time to improve outcomes and survival.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiology; Neurodegenerative disease; Novel PET tracers; Oncology; PET imaging; Personalized medicine

Mesh：

Substances：

Year:  2021        PMID： 34392925      PMCID： PMC9116257          DOI： 10.1016/j.rcl.2021.05.012

Source DB:  PubMed          Journal:  Radiol Clin North Am        ISSN： 0033-8389            Impact factor:   1.947


  273 in total

1.  177Lu-/68Ga-PSMA Theranostics in Recurrent Glioblastoma Multiforme: Proof of Concept.

Authors:  Arunav Kumar; Sanjana Ballal; Madhav Prasad Yadav; S T ArunRaj; K P Haresh; Subhash Gupta; Nishikant Avinash Damle; Ajay Garg; Madhavi Tripathi; Chandrasekhar Bal
Journal:  Clin Nucl Med       Date:  2020-12       Impact factor: 7.794

2.  Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: phase 3 study.

Authors:  Osama Sabri; Marwan N Sabbagh; John Seibyl; Henryk Barthel; Hiroyasu Akatsu; Yasuomi Ouchi; Kohei Senda; Shigeo Murayama; Kenji Ishii; Masaki Takao; Thomas G Beach; Christopher C Rowe; James B Leverenz; Bernardino Ghetti; James W Ironside; Ana M Catafau; Andrew W Stephens; Andre Mueller; Norman Koglin; Anja Hoffmann; Katrin Roth; Cornelia Reininger; Walter J Schulz-Schaeffer
Journal:  Alzheimers Dement       Date:  2015-03-28       Impact factor: 21.566

3.  Increased binding of peripheral benzodiazepine receptor in mild cognitive impairment-dementia converters measured by positron emission tomography with [¹¹C]DAA1106.

Authors:  Fumihiko Yasuno; Jun Kosaka; Miho Ota; Makoto Higuchi; Hiroshi Ito; Yota Fujimura; Shoko Nozaki; Sho Takahashi; Katsuyoshi Mizukami; Takashi Asada; Tetsuya Suhara
Journal:  Psychiatry Res       Date:  2012-08-11       Impact factor: 3.222

4.  The Acidic Tumor Microenvironment as a Driver of Cancer.

Authors:  Ebbe Boedtkjer; Stine F Pedersen
Journal:  Annu Rev Physiol       Date:  2019-11-15       Impact factor: 19.318

5.  One-step radiosynthesis and initial evaluation of a small molecule PET tracer for PD-L1 imaging.

Authors:  Yinxing Miao; Gaochao Lv; Yinfei Chen; Ling Qiu; Minhao Xie; Jianguo Lin
Journal:  Bioorg Med Chem Lett       Date:  2020-09-23       Impact factor: 2.823

6.  Acidic extracellular microenvironment and cancer.

Authors:  Yasumasa Kato; Shigeyuki Ozawa; Chihiro Miyamoto; Yojiro Maehata; Atsuko Suzuki; Toyonobu Maeda; Yuh Baba
Journal:  Cancer Cell Int       Date:  2013-09-03       Impact factor: 5.722

7.  Immuno-PET Imaging of the Programmed Cell Death-1 Ligand (PD-L1) Using a Zirconium-89 Labeled Therapeutic Antibody, Avelumab.

Authors:  Elaine M Jagoda; Olga Vasalatiy; Falguni Basuli; Ana Christina L Opina; Mark R Williams; Karen Wong; Kelly C Lane; Steve Adler; Anita Thein Ton; Lawrence P Szajek; Biying Xu; Donna Butcher; Elijah F Edmondson; Rolf E Swenson; John Greiner; James Gulley; Janet Eary; Peter L Choyke
Journal:  Mol Imaging       Date:  2019 Jan-Dec       Impact factor: 4.488

8.  First-in-Human Evaluation of 18F-SynVesT-1, a Radioligand for PET Imaging of Synaptic Vesicle Glycoprotein 2A.

Authors:  Mika Naganawa; Songye Li; Nabeel Nabulsi; Shannan Henry; Ming-Qiang Zheng; Richard Pracitto; Zhengxin Cai; Hong Gao; Michael Kapinos; David Labaree; David Matuskey; Yiyun Huang; Richard E Carson
Journal:  J Nucl Med       Date:  2020-08-28       Impact factor: 11.082

9.  Amyloid and tau imaging biomarkers explain cognitive decline from late middle-age.

Authors:  Tobey J Betthauser; Rebecca L Koscik; Erin M Jonaitis; Samantha L Allison; Karly A Cody; Claire M Erickson; Howard A Rowley; Charles K Stone; Kimberly D Mueller; Lindsay R Clark; Cynthia M Carlsson; Nathaniel A Chin; Sanjay Asthana; Bradley T Christian; Sterling C Johnson
Journal:  Brain       Date:  2020-01-01       Impact factor: 13.501

10.  [11C]Methionine and [11C]PBR28 as PET Imaging Tracers to Differentiate Metastatic Tumor Recurrence or Radiation Necrosis.

Authors:  Thuy T Tran; Jean-Dominique Gallezot; Lucia B Jilaveanu; Christopher Zito; Gabriela Turcu; Keunpoong Lim; Nabeel Nabulsi; Henry Huang; Anita Huttner; Harriet M Kluger; Veronica L Chiang; Richard Carson
Journal:  Mol Imaging       Date:  2020 Jan-Dec       Impact factor: 4.488
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.